Lannion, January 24, 2025
FINANCIAL COMMUNICATIONS AGENDA
LUMIBIRD [FR0000038242 - LBIRD], the European leader for laser technologies, publishes its financial communications agenda for 2025.
| Disclosure date | Closed period | |
| FY 2024 revenues | Monday 27/01/2025 | |
| FY 2024 earnings | Tuesday 11/03/2025 | from 11/02/2025 to 11/03/2025 included |
| Q1 2025 revenues | Monday 28/04/2025 | |
| Annual Shareholders Meeting | Tuesday 29/04/2025 | |
| H1 2025 revenues | Monday 28/07/2025 | |
| H1 2025 earnings | Tuesday 23/09/2025 | from 23/08/2025 to 23/09/2025 included |
| Q3 2025 revenues | Monday 27/10/2025 |
The agenda is indicative and may be subject to change.
Closed periods, prior to the publication of earnings, during which no trading in the Company's shares is permitted, apply to managers, persons assimilated to managers and any person who has access on a regular or occasional basis to inside information of the Company.
Next date: 2024 full-year revenue on January 27, 2025 after close of trading
LUMIBIRD is one of the world's leading laser specialists. With 50 years' experience and expertise in solid-state, diode and fibre laser technologies, the Group designs, manufactures and distributes high-performance laser solutions via two divisions: Photonics and Medical. The Photonics Division designs and produces components, lasers and systems for the defence and space, environment, topography and safety, industrial and scientific, and medtech markets. The Medical branch designs and produces medical diagnostic and treatment systems for ophthalmology. The result of the merger in October 2017 between the Keopsys and Quantel Groups, LUMIBIRD, with more than 1,000 employees and over €203.6m in sales in 2023 is present in Europe, America and Asia.
LUMIBIRD shares are listed on the Euronext Paris B Compartment. FR0000038242 - LBIRD www.lumibird.com
Since 2022, LUMIBIRD is part of Euronext Tech Leaders
Contacts
| LUMIBIRD Marc Le Flohic Chairman and CEO Tel. +33(0) 1 69 29 17 00 | LUMIBIRD
Sonia Rutnam Chief Financial and Transformation Officer Tel. +33(0) 1 69 29 17 00 | Calyptus Mathieu Calleux Investors Relations Tel. +33(1) 53 65 37 91 |
Attachment
